These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 8534239)

  • 21. Myocardial viability.
    Birnbaum Y; Kloner RA
    West J Med; 1996 Dec; 165(6):364-71. PubMed ID: 9000857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of hibernating and stunned myocardium.
    Heusch G; Schulz R
    Eur Heart J; 1997 Jun; 18 Suppl D():D102-10. PubMed ID: 9183618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hibernating myocardium represents a primary downregulation of regional myocardial oxygen consumption distal to a critical coronary stenosis.
    Canty JM; Fallavollita JA
    Basic Res Cardiol; 1995; 90(1):5-8. PubMed ID: 7779061
    [No Abstract]   [Full Text] [Related]  

  • 24. Novel mechanisms mediating stunned myocardium.
    Kim SJ; Depre C; Vatner SF
    Heart Fail Rev; 2003 Apr; 8(2):143-53. PubMed ID: 12766493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ultrastructural evidence of increased tolerance of hibernating myocardium to cardioplegic ischemia-reperfusion injury.
    Milei J; Fraga CG; Grana DR; Ferreira R; Ambrosio G
    J Am Coll Cardiol; 2004 Jun; 43(12):2329-36. PubMed ID: 15193702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Particular outcomes of myocardial ischaemia: stunning and hibernation.
    Ferrari R; Visioli O
    Pharmacol Res; 1995; 31(3-4):235-41. PubMed ID: 7630864
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stunned and hibernating myocardium: possibility of intervention.
    Ferrari R; La Canna G; Giubbini R; Visioli O
    J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S5-13. PubMed ID: 1282614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Myocardial reperfusion: salvation or danger for the heart muscle? Stunning, hibernation and preconditioning: the states of endogenous cardiac protection against ischemia].
    Atar D
    Schweiz Med Wochenschr; 1997 Nov; 127(48):2008-13. PubMed ID: 9490468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Reversible left ventricular dysfunction in coronary disease (part one): myocardial stunning].
    Vlahović A; Popović A
    Med Pregl; 2000; 53(1-2):39-44. PubMed ID: 10953549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options.
    Maxwell SR; Lip GY
    Int J Cardiol; 1997 Jan; 58(2):95-117. PubMed ID: 9049675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Left ventricular dysfunction following transient ischaemia induced by transluminal coronary angioplasty. Beneficial effects of calcium antagonists against post-ischaemic myocardial stunning.
    Sheiban I; Tonni S; Benussi P; Marini A; Trevi GP
    Eur Heart J; 1993 Jul; 14 Suppl A():14-21. PubMed ID: 8370356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of adenosine on myocardial 'stunning' in the dog.
    Sekili S; Jeroudi MO; Tang XL; Zughaib M; Sun JZ; Bolli R
    Circ Res; 1995 Jan; 76(1):82-94. PubMed ID: 8001281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive assessment of myocardial stunning from short-term coronary occlusion using tagged magnetic resonance imaging.
    Kraitchman DL; Hillenbrand HB; Oznur I; Lima JA; McVeigh ER; Zerhouni EA; Bluemke DA
    J Cardiovasc Magn Reson; 2000; 2(2):123-36. PubMed ID: 11545128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop.
    Kloner RA; Bolli R; Marban E; Reinlib L; Braunwald E
    Circulation; 1998 May; 97(18):1848-67. PubMed ID: 9603540
    [No Abstract]   [Full Text] [Related]  

  • 35. Adaptation of nonrevascularized human hibernating and chronically stunned myocardium to long-term chronic myocardial ischemia.
    Wiggers H; Nielsen SS; Holdgaard P; Flø C; Nørrelund H; Halbirk M; Nielsen TT; Egeblad H; Rehling M; Bøtker HE
    Am J Cardiol; 2006 Dec; 98(12):1574-80. PubMed ID: 17145213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocardial stunning: a post-ischemic syndrome with delayed recovery.
    Allen JW; Cox TA; Kloner RA
    EXS; 1996; 76():443-52. PubMed ID: 8805810
    [No Abstract]   [Full Text] [Related]  

  • 37. Molecular and cellular mechanisms of myocardial stunning.
    Bolli R; Marbán E
    Physiol Rev; 1999 Apr; 79(2):609-34. PubMed ID: 10221990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myocardial stunning, hibernation, and ischemic preconditioning.
    Vroom MB; van Wezel HB
    J Cardiothorac Vasc Anesth; 1996 Oct; 10(6):789-99. PubMed ID: 8910163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Molecular mechanisms for protecting the heart].
    Andres J
    Folia Med Cracov; 1994; 35(1-4):22-30. PubMed ID: 8586324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ischemic event characteristics determine the extent of myocardial stunning in conscious dogs.
    Wouters PF; Van de Velde M; Van Aken H; Flameng W
    Basic Res Cardiol; 1996; 91(2):140-6. PubMed ID: 8740530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.